The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rechallenge in advanced GIST progressing to imatinib, sunitinib and regorafenib: An Italian survey.
 
Bruno Vincenzi
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Pharmamar-zeltia
Speakers' Bureau - Abbott; Lilly; PharmaMar
Research Funding - Pharmamar-zeltia
 
Margherita Nannini
No Relationships to Disclose
 
Giovanni Grignani
Research Funding - Novartis; Pfizer
 
Elena Fumagalli
No Relationships to Disclose
 
Silvia Gasperoni
No Relationships to Disclose
 
Lorenzo D'Ambrosio
No Relationships to Disclose
 
Giuseppe Badalamenti
No Relationships to Disclose
 
Angelo Paolo Dei Tos
No Relationships to Disclose
 
Lorena Incorvaia
No Relationships to Disclose
 
Paolo G Casali
Consulting or Advisory Role - Blueprint Medicines; Lilly; Merck Serono; Novartis; Pfizer; Pharmamar-zeltia
Research Funding - Amgen (Inst); Bayer (Inst); Novartis (Inst); Pharmamar-zeltia (Inst)
 
Daniele Santini
No Relationships to Disclose
 
Giuseppe Tonini
No Relationships to Disclose
 
Marco Stellato
No Relationships to Disclose
 
Giovanna Catania
No Relationships to Disclose
 
Mariella Spalato Ceruso
No Relationships to Disclose
 
Maria A. Pantaleo
Consulting or Advisory Role - Bayer; Novartis Canada Pharmaceuticals Inc; Pfizer